Related Experiment Videos
Thyroid function in clinical subtypes of major depression: an exploratory study.
Konstantinos N Fountoulakis1, Apostolos Iacovides, Philippos Grammaticos
1Laboratory of Psychophysiology, 3rd Department of Psychiatry, Aristotle University of Thessaloniki, University Hospital AHEPA, Thessaloniki, Greece. kfount@med.auth.gr
BMC Psychiatry
|April 29, 2004
Summary
This study found that thyroid antibodies are elevated in major depressive disorder patients, suggesting an autoimmune link. Thyroid function tests can help predict treatment response in depression.
Area of Science:
- Endocrinology
- Psychiatry
- Immunology
Background:
- Unipolar depression may be associated with a 'low-thyroid function syndrome'.
- Previous research has not explored the relationship between DSM-IV depressive subtypes, treatment outcomes, and thyroid function.
Purpose of the Study:
- To investigate the relationship between thyroid function and depressive subtypes in major depressive disorder.
- To explore the predictive value of thyroid function indices for treatment response in depression.
Main Methods:
- Thirty major depressive patients (DSM-IV) and 60 controls underwent clinical diagnosis (SCAN v 2.0, IPDE) and psychometric assessment (HDRS, HAS, GAF).
- Serum levels of Free-T3, Free-T4, TSH, Thyroid Binding Inhibitory Immunoglobulins (TBII), Thyroglobulin antibodies (TA), and Thyroid Microsomal Antibodies (TMA) were measured.
- Statistical analysis included MANCOVA, discriminant function analysis, and Pearson correlation.
Main Results:
- All depressive subtypes exhibited significantly higher TBII levels compared to controls.
- Atypical depressive patients showed significantly higher TMA levels than controls.
- Thyroid indices moderately discriminated between diagnostic groups and predicted treatment response with 89.47% accuracy.
Conclusions:
- Evidence suggests an autoimmune process affecting the thyroid gland in patients with depression, even without overt thyroid dysfunction.
- Thyroid autoantibodies may serve as potential biomarkers for treatment response in major depressive disorder.